Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal Anti-inflammatory and Antitumor Potential of Artepillin C

Luisa Mota da Silva

Open source

DOI
10.2174/1874467217666230426144907
Published
2023-07-13
Container
Current Molecular Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/1874467217666230426144907,
  title = {Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal
Anti-inflammatory and Antitumor Potential of Artepillin C},
  author = {Luisa Mota da Silva},
  year = {2023},
  journal = {Current Molecular Pharmacology},
  doi = {10.2174/1874467217666230426144907},
  url = {https://doi.org/10.2174/1874467217666230426144907}
}

RIS

TY  - JOUR
TI  - Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal
Anti-inflammatory and Antitumor Potential of Artepillin C
AU  - Luisa Mota da Silva
PY  - 2023
JO  - Current Molecular Pharmacology
DO  - 10.2174/1874467217666230426144907
UR  - https://doi.org/10.2174/1874467217666230426144907
ER  - 

APA

Silva, L. M. D. (2023). Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal Anti-inflammatory and Antitumor Potential of Artepillin C. Current Molecular Pharmacology. https://doi.org/10.2174/1874467217666230426144907

Source records